Generic competition · all medicines · read 12 November 2026
Is there a generic of Medroxyprogesterone Acetate, and who makes it?
Medroxyprogesterone Acetate appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 6 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 11.7 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Medroxyprogesterone Acetate appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 6 generic makers listed as marketed across them.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Where both are dated, the first generic approval came 11.7 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Injectable, Injection
Four or more generic makers listed
Brand listed as marketed: Depo-Provera. 5 generic makers with 7 generic products listed as marketed; the first generic approval is dated 28 July 2004.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Hong Kong King Friend Industrial Co Ltd | 28 July 2004 | 1 |
| Amphastar Pharmaceuticals Inc | 28 November 2017 | 2 |
| Xiromed Llc | 12 October 2018 | 1 |
| Eugia Pharma Specialities Ltd | 22 August 2022 | 2 |
| Amneal Eu Ltd | 7 June 2023 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Tablet, Oral
One to three generic makers listed
Brand listed as marketed: Provera. 1 generic maker with 3 generic products listed as marketed; the first generic approval is dated 26 July 1984.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Barr Laboratories Inc | 9 August 1996 | 3 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Injectable, Subcutaneous
Brand listed, no generic listed as marketed
Brand listed as marketed: Depo-Subq Provera 104. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.